Journal Article

Treatment patterns in stable angina: objectives and reality

W. Klein

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 3, issue suppl_O, pages O8-O11
Published in print November 2001 | ISSN: 1520-765X
Published online November 2001 | e-ISSN: 1554-2815 | DOI:
Treatment patterns in stable angina: objectives and reality

Show Summary Details


The aims of treatment for stable angina are to improve symptoms and quality of life, to prevent cardiovascular events and to prolong life. According to current guidelines, such patients require risk factor modification, education and pharmacological treatment with beta-blockers, calcium channel blockers and nitrates, with cardioprotection with aspirin, lipid-lowering drugs and angiotensin-converting enzyme inhibitors. Despite this treatment, approximately one-third of patients do not become free of angina. Various combinations of haemodynamic agents did not demonstrate significant superior efficacy in terms of exercise test parameters. Therefore, there is a strong rationale for using new combined therapeutic approaches, including metabolic drugs such as trimetazidine. As yet, there is no evidence of an effect on the progression of atherosclerotic disease or morbidity or mortality with our treatment approach. A new epidemiological survey (Angina Treatment Pattern Survey) will be carried out in several countries. This survey is designed to characterize the angina patient population to describe current practice, and to evaluate the efficacy and limits of current management.

Keywords: Ischaemia; pharmacotherapy; stable angina; trimetazidine

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.